Harnessing natural biopolymers to develop sustainable antibacterial solutions

FHS
October 8, 2024
11:39 pm

In a bid to combat the rising threat of antibacterial resistance, researchers from the Research Center for Biomass and Bioproducts, National Research and Innovation Agency (BRIN), have delved into the characteristics and applications of biomass-derived antibacterial agents.

Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical,

August 31, 2024

FDA backs new $82M mRNA manufacturing center at MIT

The Massachusetts Institute of Technology will be aiming to design and install a new continuous mRNA manufacturing platform, with help from the federal government. According

July 14, 2023

Novel learning-based framework for predicting Alzheimer’s disease progression

About 55 million people worldwide are living with dementia, according to the World Health Organization. The most common form is Alzheimer’s disease, an incurable condition

January 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.